| 14/09/13 |
Bodisen Biotech, Inc. Results for the six month period ended 30 June 2013 |
| 17/04/13 |
BODISEN BIOTECH, INC.Audited Results for the year ended 31 December 2012 |
| 20/11/12 |
Bodisen Biotech, Inc. reports Third Quarter Financial Results |
| 20/08/12 |
Bodisen Biotech, Inc. Results for the six month period ended 30 June 2012 |
| 22/05/12 |
Bodisen Biotech, Inc. reports Unaudited 2012 First Quarter Financial Results |
| 22/05/16 |
Bodisen Biotech, Inc.(ˇ°Bodisenˇ± or the ˇ°Companyˇ±)Directorate Change |
| 25/04/12 |
Results year end 31 December 2011 FINAL |
| 15/11/11 |
Bodisen Biotech, Inc. reports Unaudited Third Quarter Financial Results |
| 15/08/11 |
Bodisen Biotech, Inc. Results for the six month period ended 30 June 2011 |
| 15/04/11 |
Bodisen Biotech, Inc. reports Unaudited First Quarter Financial Results |
| 14/05/11 |
Results year end 31 December 2010 FINAL |
| 29/11/10 |
Bodisen Biotech, Inc. reports Unaudited Third Quarter Financial Results |
| 16/08/10 |
Bodisen Biotech, Inc. Results for the six month period ended 30 June 2010 |
| 17/05/10 |
Bodisen Biotech, Inc. reports Unaudited First Quarter Financial Results |
| 08/04/10 |
Results year end 31 December 2009 FINAL |
| 24/11/09 |
Bodisen Biotech, Inc. reports Unaudited Third Quarter Financial Results |
| 24/09/09 |
Bodisen Biotech, Inc.Results for the six month period ended 30 June 2009
|
| 10/06/09 |
Bodisen Biotech, Inc. reports Unaudited First Quarter Financial Results |
| 02/04/09 |
Results year end 31 December 2008 FINAL |
| 13/01/09 |
Bodisen Biotech, Inc. Directorate Change |
| 18/11/08 |
Bodisen Biotech, Inc. reports Unaudited Third Quarter Financial Results |
| 01/10/08 |
Bodisen Biotech reports that New York Federal Court presiding over the eight consolidated class actions against Bodisen and its management grants initial motion to dismiss the cases. |
| 23/09/08 |
Results for the six month period ended 30 June 2008 |
| 21/05/08 |
Bodisen Biotech, Inc. reports Unaudited First Quarter Financial Results |
| 17/04/08 |
BODISEN BIOTECH, INC.Audited Results for the year ended 31 December 2007Review and Extracts of the Form 10-K as required by the Securities and Exchange Commission |
| 25/02/08 |
Bodisen Biotech, Inc. (ˇ°Bodisenˇ± or the ˇ°Companyˇ±) Directorate Change |
| 24/11/07 |
Bodisen Biotech, Inc. reports Unaudited Third Quarter Financial Results |
| 28/09/07 |
Bodisen Biotech, Inc. Interim Results for the six month period ended 30 June 2007 |
| 21/08/07 |
Bodisen Board of Directors Selects Auditor |
| 13/08/07 |
Bodisen Biotech Suffers Product and Raw Material Loss Due to Flooding |
| 29/07/07 |
Bodisen Biotech Contract Win & Management changes |
| 23/07/07 |
Bodisen Biotech Reports Unaudited First Quarter Financial ResultsReview & Extracts of the Form10Q as required by the Securities & Exchange Commission |
| 25/06/07 |
Additional Listing |
| 16/04/07 |
Bodisen Biotech, Inc. Preliminary Financial Results for Fiscal Year 2006 |
| 28/03/07 |
AMEX UPDATE |
| 20/03/07 |
BODISEN BIOTECH ANTICIPATES NOTICE OF DELISTING FROM THE AMEX, ANNOUNCES THAT IT WILL DELAY THE FILING OF ITS ANNUAL REPORT ON FORM 10-K AND PROVIDES UPDATED INFORMATION REGARDING STOCK OWNERSHIP |
| 08/01/07 |
Bodisen Biotech Provides 2006 Updated Guidance and Operations Update Company Provides Update on Xinjiang Factory, Signs $43.8 Million in Contracts from November Trade Shows |
| 08/01/07 |
Bodisen Biotech Provides 2006 Updated Guidance and Operations Update |
| 08/01/07 |
Bo Chen Elected as Chairman and CEO of Company |
| 05/01/07 |
Bodisen Biotech Receives Preliminary Determination from Amex |
| 05/01/07 |
Bodisen Biotech Provides Clarifying Information on Past Consulting Relationship with New York Global Group |
| 17/11/06 |
BODISEN BIOTECH ANNOUNCES RECORD DATE FOR ANNUAL SHAREHOLDERS MEETING |
| 17/11/06 |
Bodisen Biotech, Inc. AGM Notice and Proxy Statement |
| 16/11/06 |
BODISEN BIOTECH RESPONDS TO CLASS ACTION LAWSUIT |
| 15/11/06 |
Trading Update |
| 14/11/06 |
Bodisen Biotech Reports Third Quarter Financial Results Review & Extracts of the Form10Q as required by the Securities & Exchange Commission |
| 12/11/06 |
Bodisen Biotech, Inc. |
| 12/09/06 |
Bodisen Biotech, Inc Update re. Placing of 380,179 shares of common stock of $0.0001 each |
| 14/08/06 |
Bodisen Biotech, Inc. Interim Results for the year ended 30 June 2006 Review and Extracts of the Form 10-KSB as required by the Securities and Exchange Commission |
| 30/06/06 |
Trading Statement |
Releases on AIM